Consensus statement to Schering-Plough Pharmaceuticals from the health care community regarding Rebetron development and marketing.

Source :: Notes from the underground (New York, N.Y.) [Notes Undergr] 1999 Spring (No 39), pp. 9-13.
Publication Year :: 1999

Subjects :: Chemistry, Pharmaceutical
Drug Combinations
Humans
Interferons
Ribavirin
United States
Antiviral Agents
Health Services Accessibility
Hepatitis C drug therapy
Interferon-alpha
Patient Advocacy
Patient Satisfaction

Tools